Table 1 Patient and Tumour characteristics
From: Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancer
Median age = | 84.3 (53.7-92.5) years |
|---|---|
Histopathology | Invasive adenocarcinoma = 12 Mixed Tubular + Cribriform = 1 Not available = 4 |
Median ER (estrogen receptor) H score | 185 (IQR, 97.5-222) |
Median Disease Free Interval (DFI) | 84 (IQR, 19-180) months |
Metastatic Sites | Bone = 6 Pleura/Effusion = 4 Lung = 2 Liver = 5 Supraclavicular/mediastinal Lymph node = 2 |
Median lines of therapy prior to withdrawal | 5 (range 1-9) |
Median TTP (time to progression) on endocrine agent prior to withdrawal | 6 (IQR, 3-17) months |